Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL DEVICE NEWS IN BRIEF
January 7, 2008
- NHI Drug Prices to Receive 5.2% Cut in April 2008
January 7, 2008
- Concurrent Use of Unapproved Drugs with Insurance-Covered Healthcare to Be Allowed
January 7, 2008
- Mean Gap of 6.9% Found between Market Prices and NHI Prices
January 7, 2008
- Banyu Commemorates 1st Anniversary of Preminent Launching
January 7, 2008
- Korosho, MOF Agree on 0.38% Increase in Medical Fees
January 7, 2008
- GENERICS NEWS IN BRIEF
January 7, 2008
- Gov't Decides to Increase Medical Fees 0.38%
January 7, 2008
- Kyowa Pharm. Ind. to Launch 20 New Products Every Year
January 7, 2008
- BUSINESS NEWS IN BRIEF
January 7, 2008
- SSP Revises Business Forecast Upward
January 7, 2008
- NEW PRODUCTS
January 7, 2008
- Taisho to Launch RiUP Plus
January 7, 2008
- GSK Launches 1st Anticancer Drug Under New Specialist MR System
January 7, 2008
- New OTC Drug Marketing System to Create New Market: Mr Matsumoto
January 7, 2008
- Eisai to Market Stronger Neo Minophagen C in Japan, Euro-Asia Markets
January 7, 2008
- Isoconazole, Emedastine to Be Switched to OTC
January 7, 2008
- AstraZeneca to Revise Invoice Prices as Market Conditions Change
January 7, 2008
- R&D NEWS IN BRIEF
January 7, 2008
- aRigen Licenses ARB-CF0223 to Axentis
January 7, 2008
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…